B2M and esophageal squamous cell carcinoma: After PFS analysis and summarizing the B2M staining results and the related clinical information (Fig. 6a and Supplementary Table S3), we found that B2M expression in tumors was associated with the poor prognoses of ESCC patients (p = 0.039; Fig. 6b).